Trial Profile
Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary) ; Oxytocin (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- Sponsors Oxytone Bioscience
- 20 Nov 2019 Status changed from suspended to discontinued.
- 13 Mar 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.
- 13 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Jul 2019.